Middle East & Africa Respiratory Inhalers Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)
The Middle East & Africa respiratory inhalers market is expected to grow from US$ 1,541.66 million in 2022 to US$ 2,050.66 million by 2028. It is estimated to register a CAGR of 4.9% from 2022 to 2028.
Increasing Adoption of Smart Inhalers Technology is Fueling Middle East & Africa Respiratory Inhalers Market
Smart inhalers aim to help people suffering from asthma ensure they take their medication as prescribed by recording the timing and dosage on their smartphones. The data collected can be used by a clinician to verify that the prescribed treatment is working, personalize asthma reviews to focus on the root causes of worsening symptoms, and provide early warning systems that inform when to visit a clinic. This technology could shift from one-size-fits-all asthma screening and lead to fewer routine appointments. Smart inhalers benefit adults and the geriatric population, as they struggle to take the same puffs due to uneven breathing as the muscles that support breathing and the diaphragm weaken with age, preventing air from inhaling or exhaling. Smart inhalers that are equipped with sensors can be connected to conventional inhalers and help to keep track of when the medication is taken. Being Bluetooth-enabled, they can also be remotely paired with a computer or smart device, such as a phone or tablet, to transfer data from the smart inhaler automatically. Therefore, the above-mentioned applications of smart inhalers and their growing adoption are expected to provide growth opportunities to the respiratory inhalers market in the coming years.
Middle East & Africa Respiratory Inhalers Market Overview
The Middle East & Africa respiratory inhalers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022. The market is driven by a vast population base and an increase in the prevalence of respiratory diseases. The government of Saudi Arabia is promoting and offering several incentives for the domestic manufacturing of medical devices, which can drive the overall market in this country. As per the study conducted by Boehringer Ingelheim in 2018, there were more than 7,800 people with COPD in Saudi Arabia. COPD prevalence is booming in Saudi Arabia because of the rapidly expanding cases of smoking among the population. The prevalence of COPD in the Kingdom is 2.4%. In addition, the burden of asthma in Saudi Arabia is rising as the overall prevalence of asthma in children from Saudi Arabia has been reported to range from 8% to 25% based on studies conducted over the past three decades. Hence, the increasing prevalence of chronic respiratory diseases is leading the market’s growth.
Middle East & Africa Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Respiratory Inhalers Market Segmentation
The Middle East & Africa respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Middle East & Africa respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.
Based on technology, the Middle East & Africa respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Middle East & Africa respiratory inhalers market in 2022.
Based on disease indication, the Middle East & Africa respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.
Based on country, the Middle East & Africa respiratory inhalers market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Middle East & Africa respiratory inhalers market.
Increasing Adoption of Smart Inhalers Technology is Fueling Middle East & Africa Respiratory Inhalers Market
Smart inhalers aim to help people suffering from asthma ensure they take their medication as prescribed by recording the timing and dosage on their smartphones. The data collected can be used by a clinician to verify that the prescribed treatment is working, personalize asthma reviews to focus on the root causes of worsening symptoms, and provide early warning systems that inform when to visit a clinic. This technology could shift from one-size-fits-all asthma screening and lead to fewer routine appointments. Smart inhalers benefit adults and the geriatric population, as they struggle to take the same puffs due to uneven breathing as the muscles that support breathing and the diaphragm weaken with age, preventing air from inhaling or exhaling. Smart inhalers that are equipped with sensors can be connected to conventional inhalers and help to keep track of when the medication is taken. Being Bluetooth-enabled, they can also be remotely paired with a computer or smart device, such as a phone or tablet, to transfer data from the smart inhaler automatically. Therefore, the above-mentioned applications of smart inhalers and their growing adoption are expected to provide growth opportunities to the respiratory inhalers market in the coming years.
Middle East & Africa Respiratory Inhalers Market Overview
The Middle East & Africa respiratory inhalers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022. The market is driven by a vast population base and an increase in the prevalence of respiratory diseases. The government of Saudi Arabia is promoting and offering several incentives for the domestic manufacturing of medical devices, which can drive the overall market in this country. As per the study conducted by Boehringer Ingelheim in 2018, there were more than 7,800 people with COPD in Saudi Arabia. COPD prevalence is booming in Saudi Arabia because of the rapidly expanding cases of smoking among the population. The prevalence of COPD in the Kingdom is 2.4%. In addition, the burden of asthma in Saudi Arabia is rising as the overall prevalence of asthma in children from Saudi Arabia has been reported to range from 8% to 25% based on studies conducted over the past three decades. Hence, the increasing prevalence of chronic respiratory diseases is leading the market’s growth.
Middle East & Africa Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Respiratory Inhalers Market Segmentation
The Middle East & Africa respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Middle East & Africa respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.
Based on technology, the Middle East & Africa respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Middle East & Africa respiratory inhalers market in 2022.
Based on disease indication, the Middle East & Africa respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.
Based on country, the Middle East & Africa respiratory inhalers market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Middle East & Africa respiratory inhalers market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Respiratory Inhalers Market – by Product Type
1.3.2 Middle East & Africa Respiratory Inhalers Market – by Technology
1.3.3 Middle East & Africa Respiratory Inhalers Market – by Disease Indication
1.3.1 Middle East & Africa Respiratory Inhalers Market – by Country
2. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – MIDDLE EAST & AFRICA ANALYSIS
6.1 Middle East & Africa Respiratory Inhalers Market Revenue Forecast and Analysis
7. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 Middle East & Africa Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 Middle East & Africa Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Middle East & Africa: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Saudi Arabia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 Saudi Arabia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.2 Saudi Arabia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.1.3.3 Saudi Arabia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.1.4 Saudi Arabia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.1.5 Saudi Arabia Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 South Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 South Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.2 South Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.2.3.3 South Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.2.4 South Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.2.5 South Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.3 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UAE: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 UAE: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.2 UAE: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.3.3.3 UAE: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.3.4 UAE: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.3.5 UAE Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Rest of Middle East & Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.4.3.2 Rest of Middle East & Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.4.3.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Respiratory Inhalers Market – by Product Type
1.3.2 Middle East & Africa Respiratory Inhalers Market – by Technology
1.3.3 Middle East & Africa Respiratory Inhalers Market – by Disease Indication
1.3.1 Middle East & Africa Respiratory Inhalers Market – by Country
2. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – MIDDLE EAST & AFRICA ANALYSIS
6.1 Middle East & Africa Respiratory Inhalers Market Revenue Forecast and Analysis
7. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 Middle East & Africa Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 Middle East & Africa Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Middle East & Africa: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Saudi Arabia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 Saudi Arabia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.2 Saudi Arabia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.1.3.3 Saudi Arabia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.1.4 Saudi Arabia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.1.5 Saudi Arabia Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 South Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 South Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.2 South Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.2.3.3 South Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.2.4 South Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.2.5 South Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.3 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UAE: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 UAE: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.2 UAE: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.3.3.3 UAE: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.3.4 UAE: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.3.5 UAE Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Rest of Middle East & Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.4.3.2 Rest of Middle East & Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.4.3.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 3. Saudi Arabia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 4. Saudi Arabia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. South Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. UAE Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. UAE Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 15. UAE Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 16. UAE Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. UAE Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 18. UAE Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Middle East & Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of Middle East & Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Middle East & Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Middle East & Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Middle East & Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies
Table 26. Recent Organic Growth Strategies
Table 27. Glossary of Terms
Table 1. Saudi Arabia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 3. Saudi Arabia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 4. Saudi Arabia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. South Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. UAE Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. UAE Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 15. UAE Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 16. UAE Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. UAE Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 18. UAE Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Middle East & Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of Middle East & Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Middle East & Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Middle East & Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Middle East & Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies
Table 26. Recent Organic Growth Strategies
Table 27. Glossary of Terms
LIST OF FIGURES
Figure 1. Middle East & Africa Respiratory Inhalers Market Segmentation
Figure 2. Middle East & Africa Respiratory Inhalers Market, by Country
Figure 3. Middle East & Africa Respiratory Inhalers Market Overview
Figure 4. Middle East & Africa Respiratory Inhalers Market, By Product
Figure 5. Middle East & Africa Respiratory Inhalers Market, By Country
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. Middle East & Africa Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Middle East & Africa Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Middle East & Africa: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 1. Middle East & Africa Respiratory Inhalers Market Segmentation
Figure 2. Middle East & Africa Respiratory Inhalers Market, by Country
Figure 3. Middle East & Africa Respiratory Inhalers Market Overview
Figure 4. Middle East & Africa Respiratory Inhalers Market, By Product
Figure 5. Middle East & Africa Respiratory Inhalers Market, By Country
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. Middle East & Africa Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Middle East & Africa Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Middle East & Africa: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
